Targeted metabolomic analysis in Parkinson’s disease brain frontal cortex and putamen with relation to cognitive impairment
Abstract We performed liquid chromatography tandem mass spectrometry analysis with the targeted metabolomic kit Biocrates MxP Quant 500, in human brain cortex (Brodmann area 9) and putamen, to reveal metabolic changes characteristic of Parkinson’s disease (PD) and PD-related cognitive decline. This...
Main Authors: | Karel Kalecký, Teodoro Bottiglieri |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-06-01
|
Series: | npj Parkinson's Disease |
Online Access: | https://doi.org/10.1038/s41531-023-00531-y |
Similar Items
-
One-Carbon Metabolism in Alzheimer’s Disease and Parkinson’s Disease Brain Tissue
by: Karel Kalecký, et al.
Published: (2022-01-01) -
Impaired mesial frontal and putamen activation in Parkinson's disease: a positron emission tomography study.
by: Playford, E, et al.
Published: (1992) -
Phospholipid Profiles Are Selectively Altered in the Putamen and White Frontal Cortex of Huntington’s Disease
by: Gabrielle R. Phillips, et al.
Published: (2022-05-01) -
IMPAIRED ACTIVATION OF MESIAL FRONTAL-CORTEX DURING SELF-PACED MOVEMENTS IN PARKINSONS-DISEASE
by: Jenkins, I, et al.
Published: (1994) -
Gene therapy in the putamen for curing AADC deficiency and Parkinson's disease
by: Paul Wuh‐Liang Hwu, et al.
Published: (2021-09-01)